Petition Urges FDA To Take Oral Sodium Phosphate Laxatives Off OTC Market
This article was originally published in The Tan Sheet
Executive Summary
FDA should switch oral sodium phosphate bowel cleansers from over-the-counter to prescription status due to safety concerns or take them off the market altogether, according to a Sept. 20 citizen petition